This inventor holds 1 USPTO granted patent. Top assignee: Nitta Gelatin Inc.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: The Innovative Contributions of Masayuki Yasutomi
Introduction
Masayuki Yasutomi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on improving the testing methods for anticancer drugs, which is crucial for advancing cancer treatment.
Latest Patents
Masayuki Yasutomi holds a patent for a "Method for testing the sensitivity of anticancer drug." This invention relates to a method of testing the sensitivity of cancer drugs using cancer cells cultured in vitro. The method involves culturing cancer cells in a collagen gel substrate, which allows for the proliferation of various human cancer cell types. However, the presence of fibroblast cells can hinder the measurement of cancer cell growth. Yasutomi's invention addresses this issue by utilizing an image processor to selectively extract the image signals of cancer cells and their colonies. Additionally, the growth of cancer cells can be determined by measuring the volume of colonies, providing effective results within a short period.
Career Highlights
Masayuki Yasutomi is associated with Nitta Gelatin Inc., where he continues to contribute to research and development in the field of cancer treatment. His innovative approach to testing drug sensitivity has the potential to enhance the efficacy of anticancer therapies.
Collaborations
Yasutomi has collaborated with notable colleagues, including Masahiro Koezuka and Naohito Kondo. Their combined expertise in the field of cancer research has likely contributed to the advancement of innovative solutions in drug testing.
Conclusion
Masayuki Yasutomi's work exemplifies the importance of innovation in cancer research. His patented method for testing drug sensitivity represents a significant advancement in the field, potentially leading to more effective cancer treatments. His contributions, along with collaborations with esteemed colleagues, highlight the collaborative nature of scientific progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile